Research Topics
| Matti LehtinenSummaryAffiliation: University of Tampere Country: Finland Publications
| Collaborators
|
Detail Information
Publications
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trialMatti Lehtinen
University of Tampere, School of Public Health, Tampere, Finland
Lancet Oncol 13:89-99. 2012..We report vaccine efficacy against CIN3+ and adenocarcinoma in situ (AIS) in the end-of-study analysis of PATRICIA (PApilloma TRIal against Cancer In young Adults)...
Three factor eating questionnaire-R18 as a measure of cognitive restraint, uncontrolled eating and emotional eating in a sample of young Finnish femalesSusanna Anglé
School of Public Health, University of Tampere, Tampere, Finland
Int J Behav Nutr Phys Act 6:41. 2009..abstract:..
Vaccination against human papillomaviruses shows great promiseMatti Lehtinen
National Public Health Institute, Department of Infectious Disease Epidemiology, 00300 Helsinki, Finland
Lancet 364:1731-2. 2004
Preparations for implementing human papillomavirus vaccination should beginMatti Lehtinen
National Public Health Institute, Oulu, Finland
Euro Surveill 10:E050915.1. 2005
Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countriesMatti Lehtinen
National Public Health Institute, Department of Infectious Disease Epidemiology, KTL, Oulu, Finland
Vaccine 24:S3/233-41. 2006..Much of the research is already ongoing. Depending on the results of the planned immuno bridging studies among HIV-negative and HIV-positive women, further phase III and/or phase IV trials may be warranted...
Maternal Epstein-Barr virus and cytomegalovirus infections and risk of testicular cancer in the offspring: a nested case-control studyKatsiaryna Holl
Department of Child and Adolescent Health, National Public Health Institute, Oulu, Finland
APMIS 116:816-22. 2008..05, 7.04). In contrast, offspring of CMV IgG-seropositive mothers had a decreased risk of TC diagnosed under 8 years of age (OR, 0.35; 95% CI, 0.14, 0.89). Our results suggest that EBV and CMV infections may be associated with TC...
Associations between three types of maternal bacterial infection and risk of leukemia in the offspringMatti Lehtinen
National Public Health Institute, Helsinki, Finland
Am J Epidemiol 162:662-7. 2005..8, 95% confidence interval: 1.1, 6.9). Since H. pylori immunoglobulin G indicates chronic carriage of the microorganism, early colonization of the offspring probably differs between Iceland and Finland, two affluent countries...
Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanksAline Simen Kapeu
National Public Health Institute, P O Box 310, 90101 Oulu, Finland
Am J Epidemiol 169:480-8. 2009..This study confirms that smoking is an independent risk factor for cervical cancer/SCC in women infected with oncogenic HPVs. These findings emphasize the importance of cervical cancer prevention among women exposed to tobacco smoke...
A discrepancy of Chlamydia trachomatis incidence and prevalence trends in Finland 1983-2003Erika Lyytikäinen
National Public Health Institute, Oulu and Helsinki, Finland
BMC Infect Dis 8:169. 2008..We studied C. trachomatis occurrence during the past 20 years in Finland comparing incidence rate data based on serology and reported C. trachomatis laboratory notifications...
Chlamydial antibodies and risk of prostate cancerTarja Anttila
National Public Health Institute, Oulu, Finland
Cancer Epidemiol Biomarkers Prev 14:385-9. 2005..Whether the inverse relationship is true or due to difficulties in measuring the true exposure in prostatic tissue by serology, confounders or other sources of error remain open...
Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infectionAline Simen-Kapeu
National Public Health Institute, Youth Sexual Health Unit, Oulu, Finland
Scand J Infect Dis 40:745-51. 2008..1, 95% CI 0.0-0.8). Smoking did not affect the development of HPV antibody responses in women over 30 y of age. Our results suggest that smoking may induce impaired antibody response in HPV16/18-infected young women...
Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: a nested case-referent studyKatsiaryna Holl
Department of Child and Adolescent Health, National Institute for Health and Welfare, Oulu, Finland
Int J Cancer 124:2923-8. 2009..98-1,090). We report the first direct evidence that interplay of maternal steroid hormones in the early pregnancy is important in the etiology of TC in the offspring...
Risk of being seropositive for multiple human papillomavirus types among Finnish and Ugandan womenProscovia Bazanya Namujju
National Institute for Health and Welfare, Oulu, Finland
Scand J Infect Dis 42:522-6. 2010..In addition to biological and behavioural factors, iatrogenic and societal factors (screening vs no screening) may also result in the different occurrence of infections with the high-risk HPV types in Finland and Uganda...
Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessingMatti Lehtinen
University of Tampere, Tampere, Finland
Int J STD AIDS 17:517-21. 2006..This enrolment in addition to our earlier enrolment in another phase III trial guarantees enough power so that by 2020 we can ultimately provide data on the efficacy of HPV16/18 vaccination against CIS+...
Association of serum 25-hydroxyvitamin D (25-OHD) concentrations with maternal sex steroids and IGF-1 hormones during pregnancyAdetunji T Toriola
National Institute for Health and Welfare, Oulu, Finland
Cancer Causes Control 22:925-8. 2011..Vitamin D may influence circulating levels of sex steroid hormones in women during reproductive life, but associations in pregnant women have not been explored...
Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years laterMatti Lehtinen
Department of Infectious Disease Epidemiology and Microbiology, National Public Health Institute, Helsinki, Finland
Am J Obstet Gynecol 188:49-55. 2003..Our purpose was to evaluate whether antibodies to HPV16 and HPV18 E6 and E7 proteins are useful for early diagnosis of cervical cancer by measuring the antibody response in women in whom cervical cancer later developed...
Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspringMatti Lehtinen
Department of Infectious Disease Epidemiology, National Public Health Institute, Helsinki, Finland
Am J Epidemiol 158:207-13. 2003..9, 95% confidence interval: 1.5, 5.8). Results indicate that reactivation of maternal EBV infection is probably associated with childhood ALL...
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countriesPentti Tuohimaa
Medical School, University of Tampere, Tampere, Finland
Int J Cancer 108:104-8. 2004..It is recommended that vitamin D deficiency be supplemented, but too high vitamin D serum level might also enhance cancer development...
Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer: joint effect with vitamin D?Calypse B Agborsangaya
Tampere School of Public Health, University of Tampere, Tampere, Finland
Eur J Cancer 47:116-20. 2011..We studied, prospectively, the association of EBV and vitamin D status with the risk of pregnancy-associated breast cancer (PABC), breast cancer diagnosed during pregnancy or 1 year post-partum, using a nested case-control study...
Geographic distribution of cervical cancer-associated human leucocyte antigens and cervical cancer incidence in FinlandFelipe A Castro
National Public Health Institute, Oulu, Finland
Int J STD AIDS 18:672-9. 2007..Whether or not HLA type determines also regional susceptibility to persistent HPV infection, and the success of HPV vaccination in preventing both the persistent infection and CxCa warrants further investigation...
Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in FinlandPäivi Laukkanen
National Public Health Institute, Helsinki and Oulu, Mannerheimintie 166, 00300 Helsinki, Finland
J Gen Virol 84:2105-9. 2003..Epidemic spread of the oncogenic HPV-16, but not the non-oncogenic HPV-types, throughout the 1980s and 1990s preceded an increase in the incidence of cervical carcinoma in fertile-aged Finnish women...
Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective studyCalypse B Agborsangaya
Tampere School of Public Health, University of Tampere, Tampere, Finland
Eur J Cancer 46:467-70. 2010..In a longitudinal study, we evaluated the association between vitamin D levels at pregnancy over time with the risk of breast cancer, and pregnancy-associated breast cancer...
Circulating insulin-like growth factor-I in pregnancy and maternal risk of breast cancerAdetunji T Toriola
National Institute for Health and Welfare, Oulu, Finland
Cancer Epidemiol Biomarkers Prev 20:1798-801. 2011..Previously, we reported a similar association in samples obtained during pregnancy. This study was conducted to further characterize the association of IGF-I during pregnancy with maternal breast cancer risk...
Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasiaMatti Lehtinen
School of Health Sciences, University of Tampere, Tampere 33014, Finland
Sex Transm Infect 87:372-6. 2011..As Chlamydia trachomatis is also linked to cervical cancer, its role as a potential co-factor in the development of cervical intraepithelial neoplasia (CIN) grade 2 or higher was examined...
Population dynamics of serologically identified coinfections with human papillomavirus types 11, 16, 18 and 31 in fertile-aged Finnish womenMarjo Kaasila
National Institute for Health and Welfare, Oulu, Finland
Int J Cancer 125:2166-72. 2009..9, 95% CI: 2.5, 6.1). Our observations favor a coinfection rather than superinfection model for the different HPV types and are not suggestive for type-replacement following HPV vaccination...
Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33Marko Merikukka
National Institute for Health and Welfare, Oulu, Finland
Int J Cancer 128:1114-9. 2011..6 (95% CI 2.1-5.9). Our findings suggest a possible competitive advantage for HPV33 over other genital HPV types in the unvaccinated population. HPV33 should be monitored for type replacement after HPV mass vaccination...
Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990sMatti Lehtinen
National Public Health Institute, Oulu and Kuopio, Finland
Int J Cancer 119:2612-9. 2006..6-9.7). Similar clustering of HPV16 and HPV6/11 infections was not found. The epidemic and the clustering may be due to high transmission probability of the hrHPV types and increase in sexual activity of the index birth cohorts...
The effects of storage time and sampling season on the stability of serum 25-hydroxy vitamin D and androstenedioneCalypse Agborsangaya
University of Tampere, Tampere, Finland
Nutr Cancer 62:51-7. 2010..Stored serum samples can be used to study disease associations with both hormones. However, sampling season needs to be taken into account for 25-OHD by considering matching and stratification and, if possible, serial sampling...
Effect of long-term storage on hormone measurements in samples from pregnant women: the experience of the Finnish Maternity CohortKatsiaryna Holl
Department of Child and Adolescent Health, National Public Health Institute, Oulu, Finland
Acta Oncol 47:406-12. 2008..In conclusion, the stored FMC serum samples can be used to study hormone-disease associations, but close matching for storage time and gestational day are necessary design components of all related biobank studies...
An increasing proportion of reported Chlamydia trachomatis infections are repeated diagnosesErika Wikström
National Institute for Health and Welfare, Helsinki, Finland
Sex Transm Dis 39:968-72. 2012..We elucidated the conflicting trends by studying incidence of repeated Chlamydia infections over time...
Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Côte d'Ivoire and Finland) with different tobacco exposureAline Simen-Kapeu
Department of Child and Adolescent Health, National Public Health Institute, P O Box 310, Oulu, 90101, Finland
Cancer Causes Control 20:163-70. 2009..In the latter, the risk was statistically significant. Our findings emphasize the need for health initiatives targeted to prevent tobacco smoking or chewing among women especially in less industrialized countries...
Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalenceProscovia B Namujju
National Institute for Health and Welfare, Oulu, Finland
BMC Res Notes 4:170. 2011..abstract:..
Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in FinlandSarah C Woodhall
University of Tampere, Tampere, Finland
J Adolesc Health 40:466-9. 2007....
Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countriesMatti Lehtinen
School of Public Health, University of Tampere, Finland
Am J Epidemiol 156:687-92. 2002..6, 1.7) and 0.7 (95% CI: 0.3, 1.6), respectively, for HPV seropositives. In the meta-analysis, the relative risk for HSV-2 was 0.9 (95% CI: 0.6, 1.3). In both sets of data, HSV-2 did not play a role in cervical carcinogenesis...
Aspects of prophylactic vaccination against cervical cancer and other human papillomavirus-related cancers in developing countriesKari Natunen
School of Health Sciences, University of Tampere, Tampere, Finland
Infect Dis Obstet Gynecol 2011:675858. 2011..Considering cost-effectiveness versus justice further research on optional vaccination strategies is warranted...
Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young womenTiina Petaja
University of Tampere, School of Public Health, Tampere, Finland
Int J Cancer 129:2147-57. 2011....
Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 yearsTiina Petaja
School of Public Health, 33014 University of Tampere, Tampere, Finland
J Adolesc Health 44:33-40. 2009..This study is the first to evaluate the immunogenicity and safety of the vaccine in males...
Maternal human polyomavirus infection and risk of neuroblastoma in the childAnnika Stolt
Department of Medical Microbiology, , Malm, Sweden
Int J Cancer 113:393-6. 2005..In summary, a comprehensive cohort using both serology and polyomavirus DNA detection found no evidence for association between BKV or JCV polyomaviruses and neuroblastoma...
Circulating enterolactone and prostate cancer risk: a Nordic nested case-control studyPar Stattin
Department of Urology, Umea University Hospital, Umea, Sweden
Int J Cancer 99:124-9. 2002..21 (95% CI = 0.91-1.60), 1.02 (95% CI = 0.59-1.76) and 0.87 (95% CI = 0.45-1.67), respectively. No support for the hypothesis that high circulating enterolactone is protective against prostate cancer was found...
Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particlesAnnika Lundstig
Department of Medical Microbiology, , Entrance 78, 20502 Malm, Sweden
J Gen Virol 86:1703-8. 2005..In conclusion, there is a low prevalence of SV40-specific antibodies in the Nordic population. The SV40 antibodies appear to have a low stability over time and their origin is not clear...
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialLuisa L Villa
Department of Virology, Ludwig Institute for Cancer Research, Sao Paulo, Brazil
Lancet Oncol 6:271-8. 2005....
High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective studyPar Stattin
Department of Urology, Umea University Hospital, Umea, Sweden
Int J Cancer 108:418-24. 2004..bottom quintile of 0.82 (95% CI = 0.60-1.14; p(trend) = 0.44). No support was found for the hypothesis that high levels of circulating androgens within a physiologic range stimulate development and growth of prostate cancer...
[Preventive vaccines against papillomavirus and cervix cancer will soon enter clinical practice]Matti Lehtinen
, Helsingfors
Lakartidningen 100:3408-12. 2003..Recruitment of adolescents into population-based phase III vaccination studies should be large to allow reliable cancer registry based evaluation of protective effect against grave dysplasia and cervical cancer...
Chlamydia pneumoniae infection and the risk of female early-onset lung cancerTarja Anttila
Int J Cancer 107:681-2. 2003
Seroepidemiology of the human polyomavirusesAnnika Stolt
Department of Medical Microbiology, , Entrance 78, Sweden
J Gen Virol 84:1499-504. 2003..The stability of the antibodies over time indicates that polyomavirus seropositivity is a valid marker of cumulative virus exposure, and polyoma VLP-based EIAs may therefore be useful for epidemiological studies of these viruses...
[A vaccine against papillomavirus infections and cancer]Matti Lehtinen
Kansanterveyslaitos, infektioepidemiologian osasto Mannerheimintie 170, 00300 Helsinki
Duodecim 118:1397-404. 2002
A population-based prospective study of Chlamydia trachomatis infection and cervical carcinomaKeng Ling Wallin
Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden
Int J Cancer 101:371-4. 2002..trachomatis in both the prediagnostic smear and in the subsequent cervical cancer. In conclusion, a prior cervical C. trachomatis infection was associated with an increased risk for development of invasive cervical cancer...
High prevalence of HPV among female students in FinlandEeva Auvinen
Department of Virology, HUSLAB Clinical Microbiology and Haartman Institute, University of Helsinki, Helsinki, Finland
Scand J Infect Dis 37:873-6. 2005..3% were positive for high-risk HPV. The study demonstrated a strikingly high HPV DNA prevalence among the young women. Self-collected samples proved to be acceptable for HPV DNA detection using liquid hybridization...
Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control studyZoltan Korodi
Department of Medical Microbiology, Lund University, MAS University Hospital, SE-20502 Malm, Sweden
Cancer Epidemiol Biomarkers Prev 14:2952-5. 2005..Our data do not support an association between serologic markers of HPV-16, HPV-18, and HPV-33 infections and risk of prostate cancer...
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analysesRuanne V Barnabas
Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom
PLoS Med 3:e138. 2006..How these vaccines will be used in countries with national cervical cancer screening programmes is an important question...
Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvantCourt Pedersen
Odense University Hospital, Odense, Denmark
J Adolesc Health 40:564-71. 2007..To establish the feasibility of vaccination in girls 10-14 years of age, we compared the immunogenicity and safety in early adolescent female individuals to those 15-25 years in whom vaccine efficacy has been demonstrated...
Preventing common sexually transmitted infections in adolescents: time for rethinkingMatti Lehtinen
Eur J Contracept Reprod Health Care 11:247-9. 2006
Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancersEero Pukkala
Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland
Acta Oncol 46:286-307. 2007..The present paper summarizes optimal study designs of biobank-based studies of cancer...
Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspringRosamaria Tedeschi
Department of Microbiology, Oncological Center, Aviano, Italy
Am J Epidemiol 165:134-7. 2007..3, 16; odds ratio = 5.6, 95% confidence interval: 1.1, 29, respectively), suggesting EBV reactivation in the mothers of non-ALL cases. EBV reactivation may be associated with a proportion of childhood leukemia...
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18Luisa L Villa
Department of Virology, Ludwig Institute for Cancer Research, R Prof Antonio Prudente 109, 4th Floor, 01509 010 Sao Paulo, SP, Brazil
Vaccine 24:5571-83. 2006..Following an initial, similar sized decline, anti-HPV responses plateaued and remained stable through end-of-study (3.0 years). No vaccine-related serious adverse experiences were reported...
Chlamydial heat shock protein 60--specific T cells in inflamed salpingeal tissueAnne Kinnunen
National Public Health Institute, Oulu, Finland
Fertil Steril 77:162-6. 2002..CONCLUSION(S): CHSP60 may be an important T-lymphocyte antigen involved in the immunopathogenesis of tubal damage associated with chronic C. trachomatis infection...
Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancerJorma Paavonen
Department of Obstetrics and Gynecology, University of Helsinki, Haartmaninkatu 2, 00290 Helsinki, Finland
Am J Obstet Gynecol 189:1287-92. 2003..The purpose of this study was to determine whether serum antibody response to the three versions of chlamydial heat shock protein 60 is associated with an increased risk for cervical cancer...
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccineSven Eric Olsson
Karolinska Institute at Danderyds Hospital, SE 182 88 Danderyd, Sweden
Vaccine 25:4931-9. 2007..We evaluated the extent to which the vaccine is able to generate HPV type-specific immune memory...
In vivo and in vitro intragenomic rearrangement of TT virusesLudmila Leppik
Division for the Characterization of Tumor Viruses, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 242, 69120 Heidelberg, Germany
J Virol 81:9346-56. 2007..These data demonstrate new features of TT viruses suggesting possible similarities to plant viruses of the family Geminiviridae, as well as raise questions about the documented plurality and diversity of anelloviruses...
Introducing human papillomavirus vaccines - questions remainJorma Paavonen
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Finland
Ann Med 40:162-6. 2008..Implementing HPV vaccine is a great opportunity but also a great challenge. However, mandatory HPV vaccination may raise many questions, and more answers are needed...
Strengthening prevention programs to eliminate cervical cancer in the Nordic countriesLena Dillner
WHO Global Reference Laboratory for HPV Diagnosis and Control, Department of Clinical Microbiology, University Hospital, Malmo, Sweden
Acta Obstet Gynecol Scand 87:489-98. 2008..The same principles as set up for organized programs and new HPV technologies may apply for screening and vaccination as key tools to eliminate cervical cancer in the Nordic countries and globally...
